Coherus Oncology (CHRS) Debt Ratio (2014 - 2026)

Coherus Oncology has disclosed Debt Ratio across 13 years of filings, most recently posting 0.14 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.14, down 17.77% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.14 (down 17.77% YoY), and the FY2025 annual result was 0.14, up 27.84% from the prior year.
• Debt Ratio came in at 0.14 for Q1 2026 at Coherus Oncology, down from 0.14 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.61 in Q1 2023 to a low of 0.07 in Q2 2024.
• The 5-year median for Debt Ratio is 0.17 (2025), against an average of 0.27.
• Across the five-year window, Debt Ratio jumped 359.28% in 2022 and tumbled 87.06% in 2024, its largest moves.
• Coherus Oncology's Debt Ratio stood at 0.51 in 2022, then declined by 22.29% to 0.4 in 2023, then tumbled by 71.72% to 0.11 in 2024, then increased by 27.84% to 0.14 in 2025, then fell by 2.63% to 0.14 in 2026.
• The last three Debt Ratio figures came in at 0.14 (Q1 2026), 0.14 (Q4 2025), and 0.07 (Q3 2025), per Business Quant data.